Material
S
pontaneous miscarriages are very common during the first trimester of pregnancy and occur in 15-20% of all recognized pregnancies (1) . To date, the mechanisms underlying spontaneous miscarriages remain largely incompletely understood. Endocrine, anatomical, genetic, hematological, infectious, and immunological causes all are suspected as etiologies. However, all of these aspects are still not clinically explained (2, 3) . Given the semiallograft nature of an embryo and allograft rejection through inflammatory pathways, spontaneous miscarriages may be triggered by inflammation. Inflammation plays a complex role in pregnancy. Both proinflammatory and anti-inflammatory microenvironments are essential at different stages of pregnancy. Therefore, deregulated inflammation may be harmful to a pregnancy, leading to miscarriages.
Despite its inherent purpose in tissue repair, uncontrolled inflammation may actually cause pathological damage and even death. To avoid this catastrophic consequence, multiple mechanisms, such as the production of the anti-inflammatory cytokine IL-10 and TGF-b or the metabolic enzyme indoleamine 2, 3-dioxygenase or arginase 1, have evolved to mitigate inflammation (4, 5) . More recently, lipid metabolites, especially arachidonic acid metabolites, are highlighted in the regulation of inflammation. Among them, lipoxin A4 (LXA4) and its analogs are thought to be the braking signal of inflammation (6, 7) . The inflammation-triggered biosynthesis of LXA4, including leukocytes that use 5-lipoxygenase (LO) to catalyze arachidonic acid into leukotriene A4, which is then taken up and converted to LXA4 by 12-LO in platelet (8, 9) , and a second biosynthetic route identified as the sequential lipoxygenation of arachidonic acid by 15-LO in epithelial cells or monocytes as well as 5-LO in neutrophils (10) , is now recognized as transcellular processes through cell-cell interactions (11) . This exquisite and complex biosynthesis mechanism suggests an important role for LXA4 in the regulation of inflammation. However, in what ways and whether LXA4 regulates pregnancy have remained unclear.
From a conventional viewpoint, miscarriages are thought to be a kind of disease. However, from a classical evolutionary perspective, miscarriages can be seen as effective protective mechanisms to ensure the survival of the fittest species. During early pregnancy, the body may well sense various intrinsic and extrinsic stresses or indications that the fetus is damaged or irreparably abnormal. Such signals that exceed intrinsic built-in thresholds trigger the rejection process, inducing a miscarriage. Stress-triggered miscarriages have been widely reported in the literature (12) (13) (14) . In contrast, it is known that glucocorticoid hormones are the major responders to various stresses, but tightly regulated for functional exertion. It is known that, in addition to receptor-based regulation (15) , the prereceptor metabolic regulation, which involves two dehydrogenase enzymes, is extremely important. The 11b-hydroxysteroid dehydrogenase (HSD) type 1, an intracellular enzyme, converts inert glucocorticoid cortisone in humans or dehydrocorticosterone in rodents into the active form, cortisol or corticosterone, whereas 11b-HSD2 catalyzes active 11-hydroxy cortisol to the inert 11-keto form cortisone (16, 17) . To date, it remains unclear whether 11b-HSD1/HSD2 plays a role in regulating pregnancy. Interestingly, glucocorticoids have been reported to suppress LXA4 in severe asthma (18) and shown to downregulate 15-LO and 12-LO, two enzymes involved in LXA4 biosynthesis (19, 20) , implying that the regulation of LXA4 by glucocorticoids might also have a role in pregnancy. This study provides evidence that spontaneous miscarriages may be triggered through stress/glucocorticoid/LXA4 pathways.
Materials and Methods

Patient samples
Sixteen patients with spontaneous abortions and 16 women with normal pregnancies were recruited for this study. The diagnosis of a spontaneous abortion as separate from a normal pregnancy was based on color Doppler ultrasonography and serum human chorionic gonadotropin inspection. We used color Doppler ultrasound to detect gestational sac, fetal pole, and fetal heart motion of women after 8-wk gestation. If the gestational sac, fetal pole, and fetal heart motion can be detected, we define it as normal pregnancy; if we only detect gestational sac and fetal pole, but failure to detect fetal heart motion, in company with the decline of human chorionic gonadotropin and progesterone, we define it as spontaneous abortion.
The patients were chosen according to the following criteria: 1) patients were 22-35 y old and known to not use cigarettes or illicit drugs, or were not suffering from any medical conditions; 2) patients had normal liver and kidney functions and did not suffer from high blood pressure or endocrine illness; 3) patients did not have in vitro fertilization-embryo transfer and infertility history; 4) none of the patients with spontaneous abortion had undergone any therapy prior to sampling; and 5) patients with abnormal karyotype were eliminated. Blood and placental villi samplings were obtained from diagnosed patients after informed consent, and the protocol was approved by the Ethical Committee of the Medical Faculty of Tongji Medical College in accordance with the Declaration of Helsinki.
Mice and pregnancy model
BALB/c mice (8 wk old and 20-25 g in weight) were purchased from Center for Medical Experimental Animals of Hubei Province (Wuhan, China) for studies approved by the Animal Care and Use Committee of Tongji Medical College. Female mice were checked for estrus and were individually caged overnight with proven fertile males for mating. The females with positive vaginal plugs present the next morning were considered to be on day 0.5 of pregnancy.
ELISA
For LXA4 detection, the human or mouse serum and human chorionic villus tissues were assessed by ELISA kits (R&D Systems, Minneapolis, MN). For 12-HETE and 15-HETE detection, the human sera were assessed by ELISA kits (Abnova, Walnut, CA). For estradiol and progesterone detection, the human or mouse serum was assessed by ELISA kits (Westang, Shanghai, China). For CCL2, TGF-b, IFN-g, IL-10, and IL-6 detection, the mouse uterus tissues were assessed by ELISA kits (R&D Systems, Minneapolis, MN), according to the manufacturer's instructions. For cortisol detection, the human serum was assessed by ELISA kits (R&D Systems). Human chorionic villus tissues and the mouse uterus tissues were homogenized in PBS (0.5 ml) containing 100 mm PMSF (SigmaAldrich, St. Louis, MO), 1% (v/v) aprotinin (Sigma-Aldrich), 2 mg/ml leupeptin (Sigma-Aldrich), and 1 mg/ml pepstatin (Sigma-Aldrich). After centrifugation, the supernatant was assessed by ELISA kits.
In addition, peripheral blood extracted from pregnant women was allowed to sit for 20 min at room temperature. The serum supernatants were transferred to a 1.5-ml Eppendorf tube and mixed quickly. After centrifugation, serum was collected and assessed by ELISA kits.
RT-PCR and real-time RT-PCR
Blood and tissues were lysed or homogenized with TRIzol reagent (Invitrogen, Carlsbad, CA), and the total RNA was extracted according to the manufacturer's instructions. A RT-PCR procedure was used to determine the expression level of mRNA (One-Step RT-PCR kit; Qiagen, Valencia, CA). The primer sequences were presented in Supplemental Table I. For real-time RT-PCR assays, the cDNA sequences of all detected genes were retrieved from the National Center for Biotechnology Information database. The primers were designed with the Oligo Primer Analysis 4.0 software (Molecular Biology Insights, Cascade, CO), and the sequences were subjected to BLAST analysis. The total RNA (100 ng) was used for reverse transcription using Superscript II RNase H reverse transcriptase (Invitrogen) in a volume of 25 ml. Next, 2 ml cDNA was amplified with SYBR Green Universal PCR Mastermix (Bio-Rad, Richmond, CA) in duplicate. The resulting data were analyzed with the comparative cycle threshold method for relative gene expression quantification against GAPDH.
Histology and immunohistochemistry
Mouse placenta and uterus tissues and human chorionic villus were fixed in a 10% neutral buffered formaldehyde solution. After dehydration procedures, the samples were blocked in paraffin, and 4-mm sections were cut with a microtome and collected for H&E and immunohistochemical staining.
The serial sections of the chorionic villus, placenta, and uterus tissues were immunohistochemically stained for 5-LO, 12-LO, 15-LO, vascular endothelial growth factor (VEGF), 11b-HSD1, and 11b-HSD2. The tissue sections were incubated overnight with primary Abs at 4˚C, followed by secondary Abs and peroxidase-labeled avidin for 30 min. Rabbit anti-5-LO, 12-LO, 15-LO, and VEGF Abs were purchased from Santa Cruz (Santa Cruz, CA), and anti-11-bHSD1 and anti-11-bHSD2 Abs were purchased from Biosynthesis Biotechnology (Beijing, China). The sections were subsequently incubated with 3,3-diaminobenzidine and counterstained with methyl green. The negative controls without primary Abs were included. The mounted slides were examined under a light microscope. The pathologist assessing the treatment effects was blind to the treatment groups.
Positive staining was judged if the cell plasma, cell membranes, or the nuclei had turned brown. The analysis of immunohistochemical staining was performed by Image-Pro Plus (IPP 6.0; Media Cybernetics, Silver Spring, MD), according to the measurement parameter mean density. The mean density was calculated by the formula, mean density = integrate OD/area sum. Intensity was averaged from 10 fields of view. The original magnification for the immunohistochemistry study was 3400.
Pontamine blue reaction
A pontamine blue reaction test was carried out to assess the status of implantation in pregnant animals. The animals were etherized, and 0.3 ml 1% pontamine blue (Sigma-Aldrich) in sterile normal saline was injected into each animal through a tail vein. To monitor the pregnancy outcomes, the pontamine blue positive/negative sites in the uterine horns were evaluated by performing laparotomy 3 min after tail i.v. injection.
Statistics
Results were expressed as mean values plus or minus SD and interpreted by repeated-measure ANOVA. Differences were considered to be statistically significant when the p value was ,0.05.
Results
Levels of LXA4 are decreased in women with spontaneous miscarriages
This study first sought to determine whether LXA4 is correlated with spontaneous miscarriages. In this regard, serum and chorionic villus tissue were collected from both women with normal pregnancies and those with spontaneous miscarriages. As shown in Fig.  1A , the serum LXA4 levels of women with spontaneous miscarriages were 3-fold decreased, compared with women with normal pregnancies. In line with this, the levels of LXA4 in chorionic villus tissue of spontaneous abortion women were found to be significantly lower than those in women with normal pregnancies (Fig. 1B) . In addition, the decrease of LXA4 levels was not due to the chromosomal abnormalities in the miscarriage patients, because the clinical genetic detection did not show abnormality. These clinical data suggest that low levels of LXA4 are correlated to women with spontaneous miscarriages.
Downregulation of enzymes catalyzing LXA4 biosynthesis in women with spontaneous miscarriages
LXA4 is the metabolite of arachidonic acid. Three enzymes are involved in its biosynthesis through one of two pathways, as follows (6, 7): arachidonic acid catalyzed to 5-hydroperoxyeicosatetraenoic acid by 5-LO, which, in turn, is converted to leukotriene A4, and then catalyzed to LXA4 by 12-LO; arachidonic acid catalyzed to 15-(S)-hydroperoxyeicosatetraenoic acid by 15-LO and further catalyzed to LXA4 by 5-LO. To validate the above data, the expressions of 5-LO, 12-LO, and 15-LO in periphery and chorionic villus were studied. As shown by RT-PCR and real-time RT-PCR in Fig. 2A and 2B, although 5-LO mRNA expression remained at similar levels in all the samples, the mRNA expressions of 12-LO and 15-LO were strikingly downregulated in women with spontaneous miscarriages. Similar changes of 12-LO and 15-LO at the protein levels were also confirmed by immunohistochemical staining (Fig. 2C, 2D ). In addition, the activities of 12-LO and 15-LO were determined by measuring the serum levels of 12-HETE and 15-HETE, the substrates of 12-LO and 15-LO. Consistently, the activities of 12-LO and 15-LO were also lower in spontaneous miscarriage women, compared with normal pregnancies (Fig. 2E) . These data suggest that the downregulation of 12-LO and 15-LO may be the reason that women with spontaneous miscarriages have much lower levels of LXA4.
LXA4 treatment prevents LPS-induced miscarriages in mouse model
To validate the above clinical data in murine miscarriages, a LPSinduced mouse miscarriage model was constructed by i.p. injection of 0.15 mg/g LPS to female mice on day 8.5 of the pregnancy. Symptomatically, the treated mice expressed vaginal bleeding and weight loss and produced no pups. When, however, the pregnant mice were given i.p. injections of LXA4 (5 mg/kg) 2 h prior to and after the administration of LPS, the LXA4 treatment appeared to inhibit the LPS-induced fetal loss (Fig. 3A) , increasing the number of viable pregnancies (Fig. 3B ) and maintaining weight gain (Fig. 3C) . Again, it was clear that LXA4 treatment, in comparison with the LPS group, significantly reduced the rate of fetal reabsorption (Fig. 3D) , suggesting that LXA4 effectively prevents LPS-induced miscarriage in pregnant mice.
The above data prompted further confirmatory investigations into the reduced LXA4 levels in LPS-induced miscarriages. Serum levels of LXA4 and mRNA expressions of 5-LO, 12-LO, and 15-LO were carefully determined after LPS administration. As expected, the LPS injections resulted in the decrease of both mRNA expressions of lipoxygenases and LXA4 levels (Fig. 3E,  3F) . Consistently, similar changes of 5-LO, 12-LO, and 15-LO at the protein levels were also confirmed by immunohistochemical staining of uterus and placenta, respectively (Fig. 3G) . Together, these data further supported the idea that the LPS-induced miscarriages are mediated by the decrease of LXA4 in pregnant mice.
Blocking LXA4 signaling induces miscarriages in pregnant mice
But was LXA4 really significant for the healthy progress of early pregnancies? A comparable approach was used to further elucidate the role of LXA4 in miscarriages. The peptide N-Boc-Phe-LeuPhe-Leu-Phe, an antagonist of LXA4 receptor (21) , was used to block LXA4 signaling pathway in pregnant mice. Administering the antagonist from day 5.5 after fertilization and at the rate of once per day for 5 d, it was found that the pregnant mice showed vaginal bleeding and weight loss as soon as 3 d after the procedure (Fig. 4A) , and no pups were born from them (n = 8) (Fig. 4B, 4C ). In contrast, the mice receiving placebo all gave birth to new pups (Fig. 4C) , suggesting that LXA4 signaling is critical for early pregnancy and its blocking may result in early loss of the pregnancy.
LXA4 antagonizes the proinflammatory effects of LPS in early pregnancies
To address the question of how LXA4 prevented LPS-induced miscarriages, focus was turned to a set of inflammation-associated factors arising from the proinflammatory properties of LPS. These inflammation-associated factors included, but were not limited to inducible NO synthase (iNOS), CCL2, TGF-b, IFN-g, IL-6, and IL-10 in the placenta 24 h after LXA4 treatment were detected by RT-PCR and real-time RT-PCR. As shown in Fig. 5A and 5B, the expressions of iNOS, CCL2, TGF-b, IFN-g, and IL-6 were downregulated, whereas IL-10 mRNA was upregulated after LXA4 treatment. ELISA results showed decreases in CCL2, IFN-g, and TGF-b and increases in IL-10 ( Fig. 5C) . Moreover, when the murine uterus and placenta tissues were analyzed by H&E staining, it was clear, even though the inflammatory alteration was not obviously manifested in the uterus, that the LPS-induced pathological changes had been reversed by LXA4 treatment (Fig. 5D ). LXA4 has been implicated in the regulation of VEGF (22, 23) . Given the importance of angiogenesis to the maintenance and development of pregnancy, we additionally determined the influence of LXA4 on the expression of VEGF. The RT-PCR result showed that LPS upregulated the expression of VEGF, which, however, was reversed by the administration of LXA4 (Fig. 5A , 5B). The similar result was further confirmed by the immunohistochemical staining (Fig. 5E ). Once again, the data suggest that LXA4 must have a central role in keeping the homeostatic balance in the inflammatory microenvironment of early pregnancy through regulating inflammation-associated factors.
Glucocorticoids are involved in the downregulation of LXA4
Glucocorticoids play an integral part in the response to stress, which, in turn, is known to be a critical factor in spontaneous miscarriages. Are decreases in LXA4 levels due to the effect of glucocorticoids during early pregnancy? To address this question, dexamethasone, in dosages of 0.5, 2.5, 5, or 10 mg/kg, were i.v. administered from day 5.5 of mice pregnancies, once per day for 5 d thereafter. Although 0.5 and 2.5 mg/kg dosages appeared not to affect the murine pregnancies or normal labor, higher dosages of either 5 or 10 mg/kg induced vaginal bleeding, indicating the occurrence of a miscarriage. In line with this result, the levels of LXA4 were significantly decreased after the administration of 5 or 10 mg/kg dexamethasone (Fig. 6A) . Similar decreases in 5-LO, 12-LO, and 15-LO were also observed in those mice (Fig. 6B, 6C ). Besides dexamethasone, we also tested corticosterone, an endogenous active glucocorticoid in mice. A consistent result was obtained (Supplemental Fig. 1 ). These data suggested that glucocorticoid hormones might be important to the regulation of the levels of LXA4 in miscarriages. 
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Glucocorticoid activity is upregulated through the 11b-HSD1/ 11b-HSD2 pathway in stress-triggered miscarriages
The above data prompted further investigation as to whether infections and noninfectious stresses induce miscarriages through the glucocorticoid/LXA4 axis. Analyzing blood samples of clinical patients with miscarriages showed none of the otherwise expected corresponding increases in the levels of cortisol (Fig. 7A) . Given that 11b-hydroxylation is a prerequisite for glucocorticoid functions and is regulated by 11b-HSD1 and 11b-HSD2 (16), the expressions of these two enzymes were, therefore, determined in patients with spontaneous miscarriages. Surprisingly, when compared with normal pregnancies, the expression of 11b-HSD1 was not changed, whereas 11b-HSD2 was strikingly decreased in chorionic villus of miscarriages at both mRNA and protein levels, evaluated by conventional RT-PCR, real-time RT-PCR, and immunohistochemical staining, respectively (Fig. 7B, 7C ). Therefore, in women with spontaneous miscarriages, reductions in 11b-HSD2 might result in increases in the villus or placenta local activity, but not blood cortisol levels.
Infection-and noninfectious stress-induced miscarriage mouse models were used to validate the above human data. Administration of LPS represented bacterial infection or inflammation-induced stress in the mouse miscarriage model. As expected, 11b-HSD1 and 11b-HSD2 were expressed in normal pregnancy. However, the expression of 11b-HSD2 was significantly downregulated in the placenta after the injection of LPS to day 8.5 of the pregnancies (Fig. 7C, 7E) . Significantly, the administration of LXA4 reversed the decrease of 11b-HSD2 (Fig. 7D, 7E) .
In addition to LPS, vesicular stomatitis virus VSV) was also used to represent a virus infection-related miscarriage model, whereas CoCl 2 was used to represent a hypoxia-related miscarriage model (24) . Vaginal bleeding was induced by i.v. injection of VSV once per day for 3 d or alternatively by s.c. injection of 20 mg/kg CoCl 2 once on day 5.5 of the pregnancies. The mice were found with vaginal bleeding, indicating successful induction of miscarriage under both conditions. A biopsy was then made of the placenta tissue to determine the above two enzymes. Similarly, the hypoxic stress by CoCl 2 or virus infection by VSV resulted in the decrease of 11b-HSD2 levels, but had no effect on 11b-HSD1 expression (Fig. 7F, 7G) .
The above data suggest that infections or stresses may induce the downregulation of HSD2, leading to increased glucocorticoid activities in early pregnancies. However, previous studies had shown that progesterone downregulated HSD2 expression, and both progesterone and estrogen were inhibitors of 11b-HSD2 activity in human placenta (25) . To discern whether the differential HSD2 levels are attributable to differential levels of progesterone and estrogen, we i.p. injected estradiol or progesterone to mice with 8.5 d pregnancy to determine the expression of 11b-HSD2 in placenta tissues. Neither estradiol nor progesterone was found to have effect on HSD2 expression, evaluated by RT-PCR, real-time RT-PCR, and immunochemical staining (Supplemental Fig. 2A-C) , suggesting that, in our system, the differences in HSD2 levels might not be attributable to the differential sex steroid hormone expression. In addition, the levels of estradiol and progesterone were also measured. The blood levels of estradiol and progesterone in spontaneous miscarriage women were found to be significantly lower than those in normal pregnancies (Supplemental Fig. 2D) . Consistently, the blood levels of estradiol and progesterone in LPS-treated pregnant mice were significantly lower than those in the pregnant mice treated with LPS plus LXA4 (Supplemental Fig. 2E ). Such striking decreases in estradiol and progesterone might be ascribed to the loss of the baby (Fig. 8) .
Discussion
To date, the molecular mechanisms underlying miscarriages remain elusive. The present study provides evidence that stresses might enhance the activity of glucocorticoids, leading to a miscarriage via the lipid mediator LXA4 pathway.
Despite the fact that inflammation plays an important role in the early stages of pregnancies and late stages preceding labor (26, 27) , mounting evidence suggests that spontaneous miscarriages are associated with a bias toward a proinflammatory cytokine profile with respect to normal pregnancies (28) . Thus, the body has to employ an elaborate mechanism to optimally and advantageously regulate inflammation in pregnancy. LXA4, a local endogenous eicosanoid, might play such a role. In counter-regulating the evolvement of inflammation, LXA4 may exert its function by inhibiting neutrophil and eosinophil recruitment and downregulating NF-kB activation (29) . Furthermore, LXA4 blocks dendritic cell IL-12 production by increasing suppressor of cytokine signaling-2 expression (30) and stimulates phagocytosis of apoptotic cells by reprogramming macrophages from M1 to M2 types (31) . In addition, LXA4 may reduce angiogenesis, cell proliferation, and fibrosis through antagonizing leukotrienes, growth factor receptors (such as VEGF and platelet-derived growth factor), and others (23) .
In other words, LXA4 may promote inflammatory resolution at different levels. However, whether LXA4 regulates pregnant inflammation remains unclear. This study has shown that LXA4 effectively inhibits LPS-induced proinflammatory factors, including iNOS, CCL2, IFN-g, and IL-6, while increasing IL-10 expression in the placenta. Perhaps more interestingly, our observations showed that the administration of LPS to pregnant mice increased mast cell density in mouse uterus and placenta, whereas the administration of LXA4 counteracted such effects, suggesting that LXA4 might regulate the migration of mast cells to the maternal-fetal interface (J. Zhao and B. Huang, unpublished observations). As a central player of inflammation, mast cells release a variety of inflammatory mediators, including histamine, proteases, and cytokines, such as IL-6, IFN-g, etc., thereby mediating inflammatory development (32, 33) . Our unpublished observations probably implicate an important role of mast cells in miscarriages. Taken together, we propose in this work that endogenous LXA4 is a key factor in keeping normal pregnancies by regulating inflammation-associated factors, mast cells, and probably others.
A key issue that remained unresolved was how LXA4 decreased in a miscarriage. It is commonly known that LXA4 is biosynthesized by lipoxygenases 5-LO/12-LO or 15-LO/5-LO. Therefore, factors that induce miscarriages might regulate activities of those enzymes. Although not all the etiologies nor mechanisms of a miscarriage are well defined, all the causes might be linked to endogenous glucocorticoids, key steroid hormones, involved in stress responses and essential for the maturation of fetal organs, growth, and preparation of the fetus for birth (34, 35) . This study found that dexamethasone negatively regulated lipoxygenases in LPS-induced murine miscarriages, a finding consistent and in line with previous reports (18) (19) (20) . Thus, glucocorticoids can be identified in this study as the molecular basis underlying decreases in LXA4 levels in a miscarriage. The exact molecular regulation pathway, however, is beyond the current study and is worthy of investigation in the future.
What has been the important finding of this study lies in finding that whereas systemic cortisols are not changed, their utilization in chorionic villus or placenta is significantly enhanced in a miscarriage. As the key part of homeostatic control mechanisms, glucocorticoids affect perhaps ∼5% of the genome. Therefore, multiple mechanisms are evolved to strictly regulate glucocorticoid signaling. Besides the regulation of its receptor, the enzymes 11b-HSD1 and 11b-HSD2 are critical for the regulation. Glucocorticoid must be hydroxylated to acquire its functional activity. The 11b-HSD1 uses NADPH to generate active glucocorticoid. In contrast, 11b-HSD2 uses NAD + to produce a dehydoxy form of glucocorticoid. In the placenta, 11b-HSD2 represents the active component of the functional placental barrier that controls the trans-placental passage of germinal centers protecting the fetus against excessive exposure (36, 37) . The reduced amount and/or activity of 11b-HSD2 in placentas, and the accompanying increase in exposure of the placenta and embryo/fetus to active germinal centers, could be a consequence of impaired placental perfusion and hypoxia (38, 39) . This study, respectively, used LPS, VSV, and CoCl 2 to construct a mouse model of miscarriage. Regardless of the cause of miscarriage, the placenta is characterized by 11b-HSD2 decreases with unchanged 11b-HSD1. This local increase of the utility of glucocorticoid is very important, because it leads to the avoidance of the systemic side effect of high concentration of glucocorticoid. However, how infections or stresses reduce the expression of 11b-HSD2 in miscarriage is not addressed in this study, and the further elucidation of the underlying mechanism is worthy of investigation.
Based on the above findings, this study proposes a common mechanism underlying the occurrence of miscarriage (Fig. 8) , providing new insights into early loss of pregnancies. This study also suggests that the administration of LXA4 might be a potential strategy to prevent miscarriages in early pregnancies.
